Men with prostate cancer are living longer than ever, and our goal is to reduce the risk of late toxicities, such as difficulty urinating or rectal bleeding, that can impact a patient’s quality of ...

A recent study from researchers at Vanderbilt University and the University of Michigan has demonstrated that a simple at-home urine test can accurately screen for prostate cancer. The findings, ...

(RTTNews) - RedHill Biopharma (RDHL) Tuesday announced that it has launched a Phase 2 trial to assess opaganib's ability to enhance darolutamide in treating metastatic castrate-resistant prostate ...

New data showed that prior malignancy may influence survival outcomes in patients with metastatic colorectal cancer, ...

Some patients who had disease progression after stopping larotrectinib achieved a response after resuming larotrectinib.

A new computational tool could help researchers identify promising drug combinations for treating cancer, according to a new ...

A new nasal delivery method for amifostine could protect healthy tissue during pancreatic cancer radiation therapy, potentially improving survival and expanding treatment options. A novel approach ...

Panelists discuss how the data from the BRAVE-AA1 and BRAVE-AA2 phase 3 trials demonstrated the safety and efficacy of baricitinib, leading to its FDA approval in 2022 as the first systemic treatment ...

More than 67,000 Americans will be diagnosed with pancreatic cancer this year. Learn more about the disease and how PanCAN can help.